Replies to post #21 on Avalon Pharmaceuticals, Inc. (AVRX)

[John266]

Avalon Pharma: Cancer Treatment Shows Promise In Phase ILast update: 6/19/2007 5:40:54 PMDOW JONES NEWSWIRES Avalon Pharmaceuticals Inc. (AVRX) late Tuesday said that a Phase I trial of AVN944, its treatment for hematologic malignancies in elderly and refractory patients, has shown continued positive interim results. The interim data indicates AVN944 is well tolerated, has dose-dependent pharmacokinetics, induces biomarkers of programmed cell death in cancer cells from patients, and demonstrates stabilized disease in almost half of the patients after one month of treatment, the Germantown, Md.-based biopharmaceutical company said. Avalon also said it continues to believe the Phase I trial will provide sufficient information to begin multiple Phase II studies. -Katherine Hunt; 415-439-6400; AskNewswires

THIS WILL NOT BE ONLY NEWS I EXPECT TO HEAR FROM MERK NOW$$$